Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club | Medical Devices | Videos
Contract Research & Services
Contract Research
Return to: PBR Home | Contract Research & Services | Contract Research | News
Search Refinements

Contract Research News

View news from other Pharmaceutical sectors:
46-60 of 2102 results
Shire completes decentralized procedure in Europe for immunoglobulin treatment Cuvitru
Shire has completed a decentralized procedure (DCP) to support approval by 17 authorities in Europe for Cuvitru (IG 20mg/ml solution for subcutaneous injection), a treatment for pediatric and adult patients with primary and certain secondary immunodeficiency disorders, a group of disorders in which part of the body's immune system is missing or does not function properly.
Contract Research & Services > Contract Research > News
ReNeuron to tackle brain cancer with exosome platform
By PBR Staff Writer
UK clinical-stage cell therapy development firm ReNeuron Group has selected glioblastoma multiforme (GBM), the most common form of brain cancer, as the initial clinical target for its exosome nanomedicine platform.
Contract Research & Services > Contract Research > News
Bristol-Myers Squibb, MD Anderson form research collaboration in immuno-oncology focused on lung cancer
Bristol-Myers Squibb and The University of Texas MD Anderson Cancer Center today announced a new clinical research collaboration to evaluate innovative strategies for the potential use of Bristol-Myers Squibb’s immuno-oncology (I-O) agents Opdivo (nivolumab) and Yervoy (ipilimumab) to treat early- and advanced-stage lung cancer patients.
Contract Research & Services > Contract Research > News
Kite Pharma, Cell Design Labs collaborate on new CAR T-Cell immunotherapies
By PBR Staff Writer
Kite Pharma and Cell Design Labs have announced a research collaboration and license agreement to develop new CAR T-Cell immunotherapies.
Contract Research & Services > Contract Research > News
Sanofi Genzyme forms multiple sclerosis research collaboration with Johns Hopkins School of Medicine
Sanofi Genzyme, the specialty care global business unit of Sanofi, announced a research collaboration with the Johns Hopkins School of Medicine that will focus on novel strategies aimed at advancing the understanding of underlying causes of disease progression in multiple sclerosis (MS).
Contract Research & Services > Contract Research > News
HTG Molecular Diagnostics signs immuno-oncology research collaboration deal with Bristol-Myers Squibb
HTG Molecular Diagnostics has formed a research collaboration agreement with Bristol-Myers Squibb to evaluate the potential for immuno-oncology molecular profiling in multiple tumor types.
Contract Research & Services > Contract Research > News
Seres Therapeutics forms research collaboration with Memorial Sloan Kettering Cancer Center
Seres Therapeutics, a microbiome therapeutics platform company, today announced that it has entered into a strategic, multi-year research collaboration with Memorial Sloan Kettering Cancer Center (MSK).
Contract Research & Services > Contract Research > News
Biosortia Pharmaceuticals launches three new oncology research projects
By PBR Staff Writer
Biosortia Pharmaceuticals has launched three new oncology research projects using microbial compounds.
Contract Research & Services > Contract Research > News
BIND Therapeutics forms Accurins development collaboration with Affilogic
BIND Therapeutics has entered into a research collaboration with privately-held biotechnology firm Affilogic, a developer of affinity proteins dubbed Nanofitins that selectively bind to specific targets.
Contract Research & Services > Contract Research > News
Researchers find new treatment for lethal resistant prostate cancers
Researchers from the Institute of Cancer Research (ICR), London, have said that a new type of drug could benefit men with aggressive prostate cancer that has stopped responding to treatment.
Contract Research & Services > Contract Research > News
AbbVie forms two oncology-focused collaborations with CytomX and argenx
By PBR Staff Writer
Research-based biopharmaceutical firm AbbVie has entered into two oncology-focused collaborations with CytomX Therapeutics and argenx.
Contract Research & Services > Contract Research > News
Basilea signs deal with BARDA for phase 3 development of ceftobiprole antibiotic
By PBR Staff Writer
Basilea Pharmaceutica has signed an agreement worth $100m with the US Department of Health for the clinical phase 3 development of ceftobiprole antibiotic.
Contract Research & Services > Contract Research > News
Astex, Genentech partner to explore combination treatment for acute myeloid leukemia
By PBR Staff Writer
Astex Pharmaceuticals has formed a clinical trial collaboration with Genentech to explore a combination treatment for acute myeloid leukemia (AML).
Contract Research & Services > Contract Research > News
Compugen achieves preclinical milestone in cancer immunotherapy collaboration with Bayer
Compugen has achieved a first preclinical milestone for CGEN-15022 pursuant to its cancer immunotherapy collaboration with Bayer.
Contract Research & Services > Contract Research > News
Presage Biosciences extends research collaboration with Takeda to discover novel cancer drug combinations
Presage Biosciences has entered into a multi-year extension of its November 2014 research alliance with Takeda Pharmaceuticals Company.
Contract Research & Services > Contract Research > News
46-60 of 2102 results